Want to use our logo?

Download the ICS Branding Pack

ICS Background

Prof Karl-Dietrich Sievert
Klinikum Lippe

ICS 2019

Open Discussion ePoster Session 31 E-Poster 3 553 Patient Bother from Anejaculation after Transurethral Resection of the Prostate

ICS 2017

Open Discussion ePoster Session 19 Open Discussion ePosters 2 342 Novel chronic tibial neuromodulation (CTNM) treatment option for OAB significantly improves urgency (UI)/Urge Incontinence (UUI) and normalizes sleep patterns

Podium Short Oral Session 25 Male Lower Urinary Tract Symptoms 1 482 Minimally Invasive Prostatic Urethral Lift (PUL) Efficacious in a Large Percentage of TURP Candidates: A Multi-center German Study after Two Years

Podium Short Oral Session 33 Prostate and Lower Urinary Tract Symptoms 559 Visibility of Characterized Periprostatic Nerve Distributions for Nerve-Sparing Radical Prostatectomy

ICS 2015

Podium Session 19 What's New in Bladder Outlet Obstruction 254 Minimally Invasive Prostatic Urethral Lift (PUL) Efficacious In A Large Percentage of Potential TURP Candidates: Mid-term Results

Podium Session 32 Neuromodulation 474 Tibial Neuromodulation: Novel Chronic Implantable Device Achieves Urinary Continence in Initial Cases

ICS 2014

Plenary Podium Session 1 Insights into Neural Pathways Investigation to Restore Innervation of the Lower Urinary Tract of Spinal Cord Injured Patients: A European Single-Center Retrospective Study with Long-term Follow-up

Plenary Podium Session 1 Insights into Neural Pathways Long-term results demonstrate efficacy of early bilateral sacral neuromodulation for the prevention of nDO after SCI

ICS 2009

Podium Poster Session 16 Lower Urinary Tract, Physiology & Treatment 172 Latissimus Dorsi Detrusor Myoplasty in patients with acontractile bladder – long term results of a multicenter study

ICS 2007

Non Discussion Abstract Session 19 Read By Title 353 Distribution of excised peripheral nerve tissue on radical prostatectomy specimen’s nerve sparing aspect

Non Discussion Abstract Session 19 Read By Title 413 The effectiveness of sub-sensory threshold in patients with a chronic neuromodulation implant

View Member Details

Karl-Dietrich Sievert

Member

Profession:Urologist
Qualifications:PhD Professor Chairman of Department/Section
Privacy:
You must be logged in to view this contact
Sign-in to ICS

Professor Karl-Dietrich Sievert serves as Section Director in Neuro-urology and Reconstructive Surgery at the Klinikum Lippe in Detmold Germany. Previously he was the Vice Chair of Urology for more than 10 years at the University Hospital of Tübingen. Throughout his career he has initiated four interdisciplinary pelvic floor continence centers, which today are the standard of care (Urology, OBGYN, Neurology, General Surgery, Geriatric, Physiotherapy), which he considers a key element of patient care. He also introduced these primary aspects into the field of research for spinal cord injured patients into the clinic. This approach became the base for SCITReCS (Spinal Cord and Tissue Regeneration Center) at the PMU in Salzburg, where new ways of enhanced SCI treatment are being explored in the large animal model. His long-term knowledge of stem cell research and tissue engineering were a great benefit linking his clinical treatment and influencing his basic research (tissue regeneration, functional recovery, pharmacotherapy, neuromodulation).

Professor Sievert received his medical degree from the Ruprecht-Karls-University Medical School in Heidelberg and the University Clinic of Mannheim in Germany where he wrote his doctoral dissertation “Selective Sacral Root Stimulation by using sinusoidal signal and specific organ frequency for the physiological bladder evacuation” under the direction of Professor Peter Alken. He completed fellowships at the University of California’s Urology Department with Professors Emil Tanagho and Tom Lue and at the Urology and Nephrology Center in Mansoura, Egypt with Professors Mohamed Ghoneim and Hassan Abol-Enein. Professor Sievert has been highly recognized for his surgical expertise by both the American (FACS) and Royal College of Surgeons (FRCS). In addition to his leading knowledge in the field of reconstructive, functional and oncological urology, he built his expertise as a highly skilled laparoscopic surgeon as well as a certified DaVinci Console Surgeon.

Professor Sievert has participated in numerous visiting professorships and international training courses, published in the fields of oncology, neuro-urology, incontinence, and reconstructive surgery and is a board member of urological and reconstructive surgery organizations. He has received funding and awards for his teaching and research and is a recurring meeting contributor for both his clinical and basic research work to the local and international community, such as the German, European, American Urology Associations, and International Continence Society, including State-of-the-Art presentations in oncology, incontinence, tissue engineering and stem cell treatments. After hosting the ESFFU-ERGURS meeting 2011 and 2013 and the 2012 AuF, Germany’s Urology Research meeting, he served Co-Chairman of the Global Congress on Lower Urinary Tracy Dysfunction meeting in Vienna, Austria 2016. Since 2007, Professor Sievert has been a Medical State Examiner (Part 2 and 3) for the German Medical licensing authorities. He is also a European School of Urology (ESU) faculty member, where he is an opinion leader, lecturer and surgical trainer. At the European Association of Urology, he is both a Master Class and European Urology Residents Program Faculty Member.

Professor Sievert’s clinical and basic research interests include oncology (investigation of advanced detection tools and reduced invasiveness for improved functional outcome using anatomical and clinical findings), neuro-urology (diagnosis and treatment of urological nerve disorders), incontinence (pathophysiology), reconstructive surgery (medical devices, tissue engineering and stem cell treatments), pharmacotherapy and progressive and innovative treatment of spinal cord injured patients, such as early SNM implantation, which he won a 2010 Klee Innovation Prize award which resulted in several patents. He has initiated novel clinical trials. In recent years he became one of the few urologic experts in the stem cell and tissue-engineering field who has focused on the real-time processes of bringing research initiatives from the laboratory to clinic.

Prof Karl-Dietrich Sievert declared on the Friday 9th May 2014 that they had the following existing or known future financial relationships or affiliations:

Neotract

  • Consultant
  • Speaker Honorarium
  • Trial participation
  • Fellowship, travel grants

Astellas

  • Consultant
  • Speaker Honorarium

Allergan

  • Consultant
  • Trial participation
  • Research grant

Karl Storz

  • Research grant

Medtronics

  • Consultant
  • Speaker Honorarium
  • Trial participation
  • Research grant

AMS

  • Speaker Honorarium
  • Fellowship, travel grants
VOLUNTARY (EXPIRED)